Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GOAT-IN-1
Cat. No.:
OB0425LY-016
Appearance:
Solid
Purity:
99.76%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
GOAT-IN-1 is a high-quality ghrelin O-acyltransferase inhibitor and associated with a variety of diseases obesity, diabetes, hyperlipidemia, metabolic, non-alcoholic fatty liver, steatohepatitis, sarcopenia, appetite control, and alcohol/narcotic dependence.
Synonyms:
GOAT-IN-1; 1452473-54-9; (4-Chloro-6-((2-methyl-6-(trifluoromethyl)pyridin-3-yl)methoxy)-1-benzothiophen-3-yl)acetic acid
CAS No.:
1452473-54-9
Compound CID:
89767718
Formula:
C18H13ClF3NO3S
Formula Weight:
415.81
Specification
Target:
Acyltransferase
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
GOAT-IN-1 can be used to study metabolic diseases and has potential therapeutic applications especially in the areas of obesity and diabetes.
